I'm never sure what to think of East 72. They seem to do deep work, but taking this report as an example
The first idea, Belron, looks super risky to me. Margins have tripled in a few short years and leverage has ballooned against this profitability. This happened after PE got involved. I don't see any real argument for pricing power so there's a distinct possibility that the business can't bear the debt long term.
The second idea, FIH and specifically BIAL, looks fairly valued vs. most comps on 10-12x 2026 ebitda, which may be a near term peak. The only argument for undervaluation on the data E72 have provided is that a private buyer might pay 24x ebitda. I own FIH but didn't find this report particularly well-argued.
The third idea is more obviously cheap, but looks very like an ego project to me, with sub-par capital allocation.
I'm just not convinced by their thinking.